Quick Summary
Covering the latest research from top Wall Street investment banks

Under a Democratic "blue wave" scenario, U.S. healthcare policy may shift toward broader coverage, lower cost burdens, and weaker vertical integration

Institution
Bernstein
Date
2026-07-20
Authors
Lance Wilkes, Courtney Breen, Lee Hambright, Susannah Ludwig, Miki Sogi, Rebecca Liang, Eve Burstein, Justin Smith, William Pickering, Jeffrey Walch, Delphine Le Louet, Nandan Kulkarni, Kevin Peterson, Adam Chow
Company
-
Ticker
-
Industry
Healthcare
Rating
-
NeutralLow confidenceThe report argues that a Democratic win in the House of Representatives, and potentially a further expansion of control, would benefit Medicaid MCOs and some hospitals, but could create valuation pressure for Medicare Advantage; overall, it is a differentiated judgment driven by policy scenarios.
AuthorsLance Wilkes, Courtney Breen, Lee Hambright, Susannah Ludwig, Miki Sogi, Rebecca Liang, Eve Burstein, Justin Smith, William Pickering, Jeffrey Walch, Delphine Le Louet, Nandan Kulkarni, Kevin Peterson, Adam Chow
CoverageUnited States
Asset classesEquity
Business segmentsMedicaid MCOs、Hospitals、Medicare Advantage、PBMs、Employer MCOs、ACA Marketplace、Specialty Pharmacy
Research firm divisions/subsidiariesBernstein(Other)、Bernstein Institutional Services LLC(Other)、Bernstein Autonomous LLP(Other)

AI summary card

Under a Democratic "blue wave" scenario, U.S. healthcare policy may shift toward broader coverage, lower cost burdens, and weaker vertical integration

Bernstein believes that if Democrats retake at least the House of Representatives in the 2026 midterm elections, the policy focus will shift from maintaining Trump-era cuts to restoring Marketplace subsidies, delaying Medicaid cuts, discussing a public option, and limiting patient out-of-pocket costs.

This report is not a single-company rating report and does not provide an overall rating or unified target price; the disclosure page lists ratings and price targets for multiple companies.
U.S. healthcare policy2026 midterm electionsMedicaid MCOMarketplace subsidiesMedicare Advantagepublic optionhealthcare affordabilityvertical integration
  • A Democratic recapture of the House is viewed as the more likely scenario, while the Senate remains close to a toss-up.
  • The report expects no major policy changes before the midterm elections; after the election, if Democrats control one or both chambers, the top policy priority will be reversing or delaying Medicaid and Marketplace-related cuts.
  • The five major policy priorities include restoring enhanced Marketplace subsidies, delaying some Medicaid cuts, discussing a public option in the 2028 primaries, limiting consumer out-of-pocket costs, and increasing breakup pressure on vertical integration after 2028.
  • In investment terms, MOH, CNC, ELV, and HCA would benefit from expectations of Democratic victories; Medicare Advantage may face limited policy risk, and HUM is more vulnerable due to business concentration and expectations for restored Stars bonuses.

Report interpretation

Overview

This report focuses on the U.S. midterm elections in 2026 and the subsequent path of healthcare policy. The authors believe that based on polling and prediction markets, Democrats are more likely to retake the House of Representatives, while the Senate outcome remains uncertain. The report emphasizes policy changes after Democrats control at least the House: first addressing Trump-era Medicaid and Marketplace cuts, then gradually shifting toward coverage expansion and healthcare affordability issues in the 2028 presidential primaries.

Core views

The core view is that the policy timeline will unfold in two stages: major changes will be limited before the midterm elections; after the midterms, if Democrats control one or both chambers, the policy focus may first fall on restoring enhanced ACA Marketplace subsidies, easing or delaying Medicaid work requirements, and limiting provider tax cuts. Entering 2027 and 2028, investors will begin to focus on the Democratic presidential primaries, where the public option may emerge as the relatively favored coverage-expansion approach, while Medicare for All may still create MCO volatility but remains less likely.

Analysis framework

The report combines polling, prediction markets, key Senate seats, CBO estimates of the impact of OBBBA, state-level public option cases, and business exposure across healthcare subsectors to infer the policy priorities under a Democratic victory scenario, and then maps those priorities to the relative impact on Medicaid MCOs, hospitals, PBMs, employer MCOs, Medicare Advantage, and related stocks.

Methodology notes

  • Policy scenario analysisMapping election outcomes to policy priorities

    Using Democratic control of the House or both chambers as scenarios to assess the direction and sequencing of the policy agenda.

    The report assumes that changes in political control after the midterms will affect healthcare policy priorities, first observing reversals of existing cuts and then new policy proposals driven by the 2028 primaries.

  • Market expectation trackingCross-validation of polling and prediction markets

    Using the latest polling, Polymarket odds, and key state seats to judge control of the House and Senate.

    The House is judged more likely to be retaken by Democrats, while the Senate depends on key states such as ME, NC, OH, AK, and TX.

  • Fiscal and coverage impact assessmentReference to CBO estimates

    Using CBO estimates of spending cuts, Medicaid coverage, and uninsured population impacts from OBBBA-related provisions to gauge room for policy reversal.

    The report treats provisions such as work requirements, provider tax, state directed payments, and ACA eligibility redeterminations as areas that Democrats may later delay or adjust.

  • Sector mappingPolicy sensitivity mapping

    Mapping coverage expansion, Medicaid funding, MA payment reform, and vertical integration regulation to different healthcare assets.

    Medicaid MCOs and hospitals are relatively favored, MA is relatively pressured, and PBMs and employer MCOs are not currently seen as key areas of new policy risk.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Medicaid MCOs(MOH、CNC、ELV)
    Positive beneficiary
    Strengths
    If Democrats push to restore Medicaid funding, delay work requirements, and limit provider tax cuts, expectations for Medicaid coverage and funding would improve.
    Weaknesses
    The benefit depends on election outcomes and legislative execution, and policy changes may mainly take the form of delays or partial reversals.
    Comparison
    Compared with PBMs, employer MCOs, and MA, Medicaid MCOs have higher direct positive sensitivity to a Democratic victory scenario.
    Risks
    A Senate that does not shift, insufficient policy compromise, state-level implementation differences, or budget constraints could weaken the upside.
  • Hospitals(HCA)
    Moderately positive
    Strengths
    Expanded Medicaid coverage and slower provider tax cuts would help hospitals' payment sources and pressure from uninsured patients.
    Weaknesses
    The benefit is less than for Medicaid MCOs, and hospital finances are also affected by labor, costs, and regional payer mix.
    Comparison
    The report says hospitals benefit less than Medicaid MCOs, but HCA is still listed as a potential beneficiary.
    Risks
    If Medicaid coverage is not meaningfully restored, or if provider tax reform continues to advance, hospital benefits may be limited.
  • Medicare Advantage(HUM等)
    Somewhat negative or under valuation pressure
    Strengths
    Direct MA cuts are viewed by the report as politically challenging, and some risk-adjustment issues may already have been addressed by the existing policy direction.
    Weaknesses
    MA may be seen as a funding source within a Democratic policy package, and Stars quality bonuses, risk adjustment, home risk assessments, and other areas could all come under scrutiny.
    Comparison
    Because of business concentration and higher market expectations for growth from restored Stars bonuses, HUM may be more affected than other MA-related companies.
    Risks
    Elimination of Stars quality bonuses, limits on prior authorizations, tighter coding-intensity scrutiny, or payment methodology reform.
  • PBMs and Employer MCOs
    Broadly neutral
    Strengths
    The report does not expect a Democratic victory to bring incremental policy risk.
    Weaknesses
    Over the long term, vertical integration among large healthcare companies could become a policy focus after 2028.
    Comparison
    Short-term policy sensitivity is lower than for Medicaid MCOs and MA.
    Risks
    If progressives and populists jointly push to break up large healthcare companies, vertically integrated business models could come under pressure.
  • ACA Marketplace
    Positively policy-sensitive
    Strengths
    Restoring enhanced Marketplace subsidies is listed as one of the most likely post-election policy changes.
    Weaknesses
    This requires political compromise and fiscal room, and may be tied to Republican-preferred tools such as HRA expansion.
    Comparison
    Compared with Medicare for All, the Marketplace and public option are more consistent with the report's view of the Democratic policy mainstream.
    Risks
    Failure to renew subsidies, tighter eligibility redeterminations, budget offset requirements, or divided government could all limit coverage expansion.

Key data

  • House control assessmentDemocrats are more likely to retake the House of RepresentativesThe report makes this judgment based on polling, historical midterm election patterns, and prediction markets, expecting net seat gains of roughly 15-20 seats.
  • Senate assessmentThe outcome remains close to a toss-upME and NC are seen as the states most likely to shift to Democrats, while OH, AK, and TX shifting would indicate a stronger blue wave.
  • Peak ACA Marketplace membership24.3mThe report states that ACA membership peaked in 2025 and may decline thereafter.
  • Potential ACA Marketplace pullback range16.5-17.5mThe report cites estimates that membership could fall to this range this year, creating the policy backdrop for restoring subsidies and expanding coverage.
  • Total OBBBA spending cuts, 2025-2034~$886bnThe table summarizes provisions such as work requirements, provider taxes, state directed payments, and ACA eligibility redeterminations.
  • Medicaid-related coverage impact5.7mnThe table shows that Medicaid-related provisions could affect about 5.7mn of Medicaid enrollment.
  • Increase in uninsured population by 20347.5mnThe total shown in the table indicates an increase of about 7.5mn in the uninsured population.
  • Scale of work requirement cuts$317.0bnThe implementation period is Jan 27-Jan 29, and the report says the policy requires work-like activities and documentation.
  • Scale of provider tax cuts$182.7bnThe implementation period is 2028-2032, and the report believes large Medicaid states that rely on provider taxes could become a legislative relief priority.
  • Scale of ACA eligibility redeterminations cuts$58.0bnThe table shows that this could affect 10% of coverage and increase the uninsured population by about 700k.

Impact & implications

From an investment perspective, a strong Democratic performance in the midterm elections would raise market expectations for the restoration of Medicaid and Marketplace funding, making Medicaid MCOs and hospitals relative beneficiaries. The report specifically names MOH, CNC, ELV, and HCA as potential beneficiaries. Medicare Advantage could face valuation pressure, with risks including elimination of Stars quality bonuses, payment methodology reform, risk adjustment, home risk assessments, chart reviews, coding intensity, and scrutiny of favorable selection; HUM is more sensitive because of its higher MA concentration. PBMs and employer MCOs are not currently viewed as facing incremental policy risk, but after 2028, breakup policies targeting vertical integration among large healthcare companies could gain momentum.

Risks

  • The election scenario itself is uncertain, especially as Senate control remains close to a toss-up.
  • The report's policy path depends on Democrats retaking at least the House; if results fall short of expectations, Medicaid- and Marketplace-related positives may be delayed or disappear.
  • Even if Democrats win, healthcare policy may still be constrained by the budget, presidential approval, Senate rules, and bipartisan compromise.
  • Although Medicare Advantage cuts are seen as a lower-probability priority, if they enter the policy package, concentrated-exposure companies such as HUM could face valuation pressure.
  • The 2028 primaries could reignite discussion of Medicare for All; although the report sees this as less likely than a public option, it could still create MCO volatility.
  • If policy efforts targeting vertical integration intensify after 2028, large healthcare platforms, PBMs, and related integrated business models could face regulatory risk.

What to watch

  • The 2026 midterm House results and the scale of Democrats' net seat gains.
  • Key Senate races in ME, NC, OH, AK, and TX, as well as changes in prediction market odds such as Polymarket.
  • Whether enhanced Marketplace subsidies are renewed, and whether they are tied to compromise proposals such as HRA expansion.
  • Whether rules related to Medicaid work requirements, provider tax reform, and state directed payments are delayed, relaxed, or partially reversed.
  • The policy agenda of the 2028 presidential primaries beginning in 2027, especially the public option, Medicare for All, and healthcare affordability proposals.
  • Whether the Democratic healthcare policy package uses MA as a funding source, with focus on Stars quality bonuses, risk adjustment, home risk assessments, and prior authorization reform.
  • Whether legislative or campaign proposals targeting vertical integration among large healthcare companies move from fringe issues to mainstream issues.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins